
Pharma’s obesity gold rush will have limits: podcast
LONDON, May 11 (Reuters Breakingviews) – Drugmakers Novo Nordisk and Eli Lilly are vying for a large slab of the weight loss medications market, which analysts reckon could be worth $100 bln by 2031. In this Viewsroom podcast, Breakingviews columnists discuss how investor optimism in a booming market is unwarranted.Listen to the podcastFollow @aimeedonnellan on… […]